Sedalis sedi-lab
Brand names,
Sedalis sedi-lab
Analogs
Sedalis sedi-lab
Brand Names Mixture
Sedalis sedi-lab
Chemical_Formula
C16H13Cl3N2OS
Sedalis sedi-lab
RX_link
http://www.rxlist.com/cgi/generic3/tioconaz.htm
Sedalis sedi-lab
fda sheet
Sedalis sedi-lab
msds (material safety sheet)
Sedalis sedi-lab
Synthesis Reference
No information avaliable
Sedalis sedi-lab
Molecular Weight
387.711 g/mol
Sedalis sedi-lab
Melting Point
No information avaliable
Sedalis sedi-lab
H2O Solubility
No information avaliable
Sedalis sedi-lab
State
Solid
Sedalis sedi-lab
LogP
4.971
Sedalis sedi-lab
Dosage Forms
Cream; Ointment; Suppository (each applicator-full provides approximately 4.6 grams of ointment containing 300 mg of tioconazole)
Sedalis sedi-lab
Indication
For the local treatment of vulvovaginal candidiasis (moniliasis).
Sedalis sedi-lab
Pharmacology
Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against Candida albicans, other species of the genus Candida, and against Torulopsis glabrata. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. This drug is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.
Sedalis sedi-lab
Absorption
Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.
Sedalis sedi-lab
side effects and Toxicity
Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning,
Sedalis sedi-lab
Patient Information
Sedalis sedi-lab
Organisms Affected
Yeast and other fungi